The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1,1,1-Trifluoro-3-hexylamino-propan-2-one ID: ALA153080
Chembl Id: CHEMBL153080
PubChem CID: 44368412
Max Phase: Preclinical
Molecular Formula: C9H16F3NO
Molecular Weight: 211.23
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCNCC(=O)C(F)(F)F
Standard InChI: InChI=1S/C9H16F3NO/c1-2-3-4-5-6-13-7-8(14)9(10,11)12/h13H,2-7H2,1H3
Standard InChI Key: VLSZWXFKEIUTAT-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 211.23Molecular Weight (Monoisotopic): 211.1184AlogP: 2.29#Rotatable Bonds: 7Polar Surface Area: 29.10Molecular Species: NEUTRALHBA: 2HBD: 1#RO5 Violations: ┄HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.51CX Basic pKa: 7.65CX LogP: 2.96CX LogD: 2.51Aromatic Rings: ┄Heavy Atoms: 14QED Weighted: 0.65Np Likeness Score: -0.39
References 1. Wheelock CE, Colvin ME, Uemura I, Olmstead MM, Sanborn JR, Nakagawa Y, Jones AD, Hammock BD.. (2002) Use of ab initio calculations to predict the biological potency of carboxylesterase inhibitors., 45 (25): [PMID:12459025 ] [10.1021/jm020072w ]